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Malignant peripheral nerve sheath tumor (MPNST) is an
uncommon type of sarcoma that arises from peripheral
nerve sheaths. The origin of this tumor is thought to be
Schwann cells or pluripotent cells of the neural crest.
About 50 % of MPNSTs are known to develop into cases
of neurofibromatosis type 1 (von Recklinghausen’s disease,
NF-1) [1]. Malignant triton tumor (MTT), which is a sub-
type of MPNST in which malignant Schwann cells coexist
with malignant rhabdomyoblasts, was firstly reported by
Masson et al. in 1932 [2]. MTT is extremely rare, and
accounts for less than 5 % of all MPNSTs [3]. The average
age of patients with MTT is 31.7 years, and the morbidity
is approximately equal in males and females [4]. MTT usu-
ally occurs in the head, neck, and trunk [3,5,6]. Other rare
positions, such as the retroperitoneal space, parapharyngeal
space, lumbar spine, cervical spine, intracardiac, and nose,
have also been reported in the literature [7-12]. Intracranial
MTT is very rare, and only four cases have been described
[13-16]. Here, we describe a case of MTT occurring in the
cerebellopontine angle.* Correspondence: lyhzhw@fmmu.edu.cn; zhwlyh@fmmu.edu.cn
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A 55-year-old female was referred to our hospital be-
cause the left angle of her mouth had been slanted and
numb for six months, and she had experienced auditory
dysesthesia for one month. Magnetic resonance imaging
(MRI) revealed that there was a small mass in the left
cerebellopontine angle. During the operation, the small
mass, which was dark red and soft in texture, was found
at the side of brainstem, and closely conglutinated with
the surrounding cranial nerves. The resected mass mea-
sured 1.2×1.0×0.8 cm, and the cut surface was dark red.
Microscopically, the tumor was composed of spindle
cells with wavy nuclei, and scattered or focal large cells
that were rounded or elongated with abundant and deep
eosinophilic cytoplasm. Cross striations were found in a
few cells. Mitotic figures were scarce (Figure 1). Immuno-
histochemically, the spindle cells showed focal positivity
for S-100 protein and nerve fibers (NFs), and the large cells
were positive for desmin and myoglobin (Figure 2). Both
cell types showed negative staining for glial fibrillary acidic
protein (GFAP), neuron specific enolase (NSE), HMB45,
melanoma-pan, cytokeratin (CK), epithelial membrane
antigen (EMA), alpha-fetoprotein (AFP), CD30, human
chorion gonadotropin (HCG), SM-action, CD68, CD163,
and CD34. Thus, we diagnosed this case as malignant per-
ipheral nerve sheath tumor with rhabdomyoblastic differ-
entiation, namely MTT.
The diagnosis of MTT was mainly based on histo-
pathological characteristics and immunohistochemicald. This is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any
ly cited.
Figure 1 Microscopically, the tumor was composed of spindle cells with wavy nucleus and scattered or focal large cells which were
rounded or elongated with abundant deep eosinophilic cytoplasm. Cross striations were found in few of them. Mitotic figures were scarce in
the cellular areas. A, ×200; B, ×200; C, ×200; D, ×400.
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criteria for MTT: 1) the tumor originates from the sur-
rounding nerve or develops into NF-1; 2) spindle cells are
the main cell type in MPNST; 3) there are true neoplastic
rhabdomyoblasts, but they are not due to involvement or
metastasis of rhabdomyosarcoma in other positions. In
our case, the characteristics, including imageology and
histopathology, were in accordance with the above three
criteria. Moreover, no masses were found in other posi-
tions. Hence we diagnosed it was a case of primary MTT
in the cerebellopontine angle.
MTT should be differentiated from the following malig-
nant tumors because of its complex and diverse histomor-
phology: 1) MPNST does not harbor rhabdomyoblastic
differentiation, although the tumor cells are spindle-shaped.
In addition, the tumor cells are negative for skeletal muscle
proteins, such as desmin and myoglobin, and are positive
for S-100 protein; 2) In malignant fibrous histiocytoma, the
tumor is composed of spindle cells and giant tumor cells.
However, the tumor cells do not express S-100 protein, des-
min, or myoglobin, but do express AACT and CD68; 3) In
leiomyosarcoma, the pattern of growth is predominantly
fascicular, with the tumor bundles intersecting each other at
wide angles. Merging of the tumor cells with blood vessel
walls is an important diagnostic clue. The individual cells
have elongated, blunt-ended nuclei and acidophilic fibrillary
cytoplasm; features that are also apparent in cytologicpreparations. Cytoplasmic vacuoles, which are located at
both ends of the nucleus, can sometimes be indented as an-
other diagnostic clue. Immunohistochemically, the tumor
cells are positive for SM-actin and desmin, but negative for
myoglobin and S-100 protein; 4) Rhabdomyosarcoma,
especially embryonal rhabdomyosarcoma, is composed of
undifferentiated rounded and spindle cells. Interestingly,
well-differentiated rhabdomyoblasts have a deeply acido-
philic cytoplasm, and are thus sometimes mis-diagnosed as
MTT. However, rhabdomyosarcoma has a different com-
position than MPNST, and the average age of patients with
this disease is younger than those with MTT. Moreover, a
feature of diagnostic value is the presence of highly cellular
areas that usually surround blood vessels, alternating with
parvicellular regions that have abundant mucoid intercellu-
lar material. Immunohistochemically, the tumor cells show
negative reactivity for S-100.
Like most soft-tissue sarcomas, MTTs are traditionally in-
sensitive to chemotherapy and radiotherapy. However, sev-
eral recent reports have suggested that neoadjuvant therapy
and adjuvant chemotherapy can eradicate micrometastasis.
Integrated positron emission tomography and computed
tomography have been used to assess remission and re-
sponse to therapy [18]. Thus, multidisciplinary treatments,
including complete resection, are required for patients with
MTT. McConnell et al. reviewed 124 cases of MTT
reported in the literature, and concluded that complete
Figure 2 Immunohistochemically, the spindle cells were positive for S-100 protein (A, ×200; B, ×200 ), and the large cells were positive
for desmin (C, ×200) and myoglobin (D, ×200).
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cornerstone of MTT treatment [19].
The prognosis of MTT is very poor, with a 5-year sur-
vival rate of only 14 % and a median time to death of
13 months. The overall local recurrence/progression
rate is 50 %, and the median time to recurrence/pro-
gression is six months [19]. In our study, the patient
was discharged on post-operative day 12 with an un-
eventful recovery. Currently, the patient is alive with no
evidence of disease after a 5-month follow-up.
There is limited information in the literature regarding
cytogenetic analyses of MTT, and only eight cases of MTT
have been previously karyotyped. Most of them showed ra-
ther complex cytogenetic deviations, although some genetic
aberrations appear to be common [20-25]. Koutsimpelas
et al. firstly analyzed the genomic imbalance of a case of
MTT using comparative genomic hybridization (CGH)
[26]. The results demonstrated the involvement of onco-
genes located at chromosomes 1, 16, 17, 19, and 22. These
studies will be important for the understanding of the
pathophysiology of MTT.Conclusions
In conclusion, intracranial MTT is extremely rare. Its diag-
nosis must be based upon histopathological characteristics
and immunohistochemical features.Consent
Written informed consent was obtained from the patient
for publication of this Case Report and any accompany-
ing images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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